SCHEMBL16886166

SCHEMBL16886166

Cc1ccc(COc2cc(F)cc(Oc3ccc(-c4nn(C)c5ncnc(N)c45)cc3)c2)s1

nearest known ligand 0.57

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ NUDT14 O95848 2/20 0.57
▸ NUDT5 Q9UKK9 2/20 0.57
▸ PIK3CD O00329 11/20 0.54
▸ PIK3CA P42336 11/20 0.54
▸ PIK3CB P42338 11/20 0.54
▸ PIK3CG P48736 11/20 0.54
▸ PRKDC P78527 11/20 0.54
▸ ABL1 P00519 10/20 0.49
▸ SRC P12931 10/20 0.49
▸ EGFR P00533 9/20 0.49
▸ HCK P08631 9/20 0.49
▸ MTOR P42345 9/20 0.49
▸ EPHB4 P54760 9/20 0.49
▸ KDR P35968 8/20 0.49
▸ PI4KB Q9UBF8 2/20 0.46
▸ BTK Q06187 6/20 0.45
▸ AURKA O14965 1/20 0.41
▸ IKBKE Q14164 1/20 0.41
▸ AURKB Q96GD4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15613749 0.90 NUDT14 (0.56) NUDT14NUDT5PIK3CDPIK3CAPIK3CB
SCHEMBL16886182 0.89 SRC (0.49) NUDT14NUDT5PIK3CDPIK3CAPIK3CB
SCHEMBL16886186 0.89 KDM4E (0.56) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL16886165 0.89 SRC (0.55) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL16886176 0.87 SRC (0.46) NUDT14NUDT5PIK3CDPIK3CAPIK3CB
SCHEMBL16886158 0.86 SRC (0.51) NUDT14NUDT5ABL1SRCEGFR
SCHEMBL16886189 0.86 MAPK1 (0.47) NUDT14NUDT5PIK3CDPIK3CAPIK3CB
SCHEMBL16886205 0.86 SRC (0.51) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL16886204 0.86 BTK (0.49) NUDT14NUDT5PIK3CDPIK3CAPIK3CB
SCHEMBL16886156 0.86 BTK (0.60) NUDT14NUDT5PIK3CDPIK3CAPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9796716-B2 Selective inhibitors of Tec and Src protein kinase families PHARMASCIENCE, INC. (CA) 2017-10-24 — — US disclosed
US-20150191473-A1 PROTEIN KINASE INHIBITORS PHARMASCIENCE, INC. (CA) 2015-07-09 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150191473-A1 PROTEIN KINASE INHIBITORS TEC, SRC, LCK NUDT14 2511/4885NUDT5 1603/4885PIK3CD 357/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback